Table 5 Ongoing symptoms after SARS-CoV-2-infection.
From: Lower SARS-CoV-2 household transmission in children and adolescents compared to adults
Time after SARS-CoV-2 | Ongoing symptoms | Male | Female | < 18 years | ≥ 18 years | < 12 years | 12–17 years | 18–40 years | > 40 years |
|---|---|---|---|---|---|---|---|---|---|
< 12 weeks | Yes | 19.7 | 30.1 | 8.2 | 32.6 | 6.3 | 10.8 | 21.3 | 40.6 |
No | 80.3 | 69.9 | 91.8 | 67.4 | 93.8 | 89.2 | 78.7 | 59.4 | |
n = 132 | n = 136 | n = 85 | n = 181 | n = 48 | n = 37 | n = 75 | n = 106 | ||
p < 0.05 | p < 0.0001 | ns | p < 0.01 | ||||||
≥ 12 weeks | Yes | 17.5 | 40.4 | 3.8 | 41.9 | 0 | 7.3 | 37.8 | 45.5 |
No | 82.5 | 59.6 | 96.2 | 58.1 | 100 | 92.7 | 62.2 | 54.5 | |
n = 160 | n = 183 | n = 105 | n = 234 | n = 50 | n = 55 | n = 111 | n = 123 | ||
p < 0.0001 | p < 0.0001 | p < 0.01 | p = 0.053 | ||||||
Time after SARS-CoV-2 | Ongoing symptoms | Seropositive | Seronegative | Symptomatic COVID-19 | Asymptomatic COVID-19 | Comorbidities | No comorbidities | BMI < 25 | BMI > 25* |
|---|---|---|---|---|---|---|---|---|---|
< 12 weeks | Yes | 31.5 | 14.5 | 33.3 | 5 | 42.5 | 17.8 | 8.2 | 0 |
No | 68.5 | 85.5 | 66.7 | 95 | 57.5 | 82.2 | 91.8 | 100 | |
n = 168 | n = 83 | n = 189 | n = 80 | n = 80 | n = 185 | n = 73 | n = 5 | ||
p < 0.001 | p < 0.0001 | p < 0.0001 | ns | ||||||
≥ 12 weeks | Yes | 34.8 | 20.8 | 39.8 | 3.1 | 41 | 24.5 | 2.2 | 22.2 |
No | 65.2 | 79.2 | 60.2 | 96.9 | 59 | 75.5 | 97.8 | 77.8 | |
n = 233 | n = 101 | n = 244 | n = 98 | n = 100 | n = 241 | n = 91 | n = 9 | ||
p < 0.001 | p < 0.0001 | p < 0.01 | p < 0.05 | ||||||
